Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Annelyn Torres-Reveron, PhD
CO-FOUNDER AND CEO, SUR180 THERAPEUTICS, INC
Sur180 Therapeutics, INC
McAllen, Texas, United States
Robert Towarnicki, MS
PRESIDENT & CEO, SIRPANT IMMUNOTHERAPEUTICS INC.
SIRPant Immunotherapeutics Inc.
Hummelstown, Pennsylvania, United States
Nolan Townsend
CEO AND DIRECTOR, LEXEO THERAPEUTICS
Accelerated Approval Under Pressure: What’s At Stake and What Can Be Done?
Raphael Townshend, PhD
FOUNDER & CEO, ATOMIC AI
Emerging RNA Therapy Platforms: The Next Generation Genetic Medicines
Atomic AI
South San Francisco , California, United States
Sharon Townson
CHIEF TECHNOLOGY OFFICER, MONTE ROSA THERAPEUTICS
From Serendipity to Rational Design, Redefining the Rules of Molecular Glue Discovery
Boston, United Kingdom
Mark Tracy, PhD
PRESIDENT, TRACY BIOCONSULTING, LLC
The Future of Non-Viral Gene Therapy: Accelerating Next-Generation Gene Therapies
Giovanni Traverso
ASSISTANT PROFESSOR, MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Targeting Success: 3 MIT Thought Leaders on Innovation
Boston, Massachusetts, United States
Nancy Travis
VICE PRESIDENT OF INTERNATIONAL AFFAIRS, BIO
Understanding Business Development Opportunities in the Asia-Pacific
Intellectual Property Law in the 118th Congress
Sarah trice, ACA
COO, HEAD OF US OPERATIONS, XTLAPI
XtalPi
Cambridge, Massachusetts, United States
Klaus Trier, MD
MD, THEIALIFE SCIENCES
Theialife Sciences
Copenhagen, Denmark